Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 45 results found. Search for [ Fixed-dose combination ]

Results 1 to 21 of 45
PTI
February 22, 2021
In Russia, allergic rhinitis affects 10-20 per cent of the population on average, with certain regions having a higher prevalence rate of 18-38 per cent


BusinessToday.In
December 23, 2020
Reversing from 4 days of consecutive fall, Glenmark Pharma stock opened higher at Rs 488 and gained 2.86% to hit the day's high of Rs 497.70 against the last close of Rs 483.85


Prasanna Mohanty
June 25, 2020
This concluding part narrates the circumstances in which market triumphed over state and spread from developed economies to developing economies, helping the top 1% to accumulate more wealth at the cost of the rest 99%


E Kumar Sharma
New Delhi, May 23, 2019
The pharma industry is today growing at around 11 per cent per annum as compared to a high of around 15 per cent about five years ago.


PTI
March 24, 2019



PTI
February 6, 2019



PTI
February 3, 2019



PTI
January 17, 2019



PTI
January 9, 2019



PTI
January 9, 2019



PTI
January 7, 2019



PTI
January 7, 2019



PTI
January 1, 2019



BusinessToday.In
New Delhi, September 17, 2018
The decision was taken after drug makers filed a petition, saying that these drugs were being manufactured since 1988. They cited the SC's earlier relief to 15 manufacturers on the bases of the similar grounds, saying that they should also be exempted from the ban.


E Kumar Sharma
New Delhi, September 13, 2018
As the industry is trying to digest the development, not totally unexpected though, there are fresh concerns on what could come next as the ministry-appointed Prof Kokate Expert committee had discussed banning many more FDC drugs.


BusinessToday.In
New Delhi, September 13, 2018
India reportedly boasts around 2,000 FDCs, four times more that what's available in the US.


BusinessToday.In
New Delhi, September 13, 2018
The FDC medicines are two or more drugs contained in a single dosage form. The health ministry says it took the decision to ban these drugs after the Drugs Technical Advisory Board suggested these drugs might pose a risk to human beings.


PB Jayakumar
New Delhi, July 27, 2018
The drugs under question are 349 fixed dose combinations drugs containing two or more active pharmaceutical ingredients in a fixed dosage ratio, which are floating in the Rs 1.1-lakh crore Indian drug market.


E Kumar Sharma
New Delhi, June 8, 2018
The Indian pharma has recently seen a perceptible slide in the number of new products hitting the market. According to the analysts, slippages are more in select therapies and they attribute this to several reasons.


Joe C Mathew
December 18, 2017
The court's observation came during a hearing that challenged a Delhi High Court order that had quashed the government ban on technical grounds.


PAGES 1 OF 3  123